We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+12.09%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$683M
AUM Growth
-$101M
Cap. Flow
-$82.5M
Cap. Flow %
-12.08%
Top 10 Hldgs %
52.33%
Holding
153
New
26
Increased
35
Reduced
53
Closed
35

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$20M
2
BIIB icon
Biogen
BIIB
+$11.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.32M
4
ORA icon
Ormat Technologies
ORA
+$5.09M
5
OPK icon
Opko Health
OPK
+$5.01M

Top Sells

Rank Stock Value
1
ESLT icon
Elbit Systems
ESLT
+$29.2M
2
SHPG
Shire pic
SHPG
+$27M
3
AGN
Allergan plc
AGN
+$23M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.7M
5
VTRS icon
Viatris
VTRS
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 60.65%
2 Utilities 5.79%
3 Technology 1.86%
4 Consumer Discretionary 1.38%
5 Communication Services 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NICE icon
126
Nice
NICE
$5.79B
– –
-4,525
Closed -$255K
OEF icon
127
PUT
iShares S&P 100 ETF
OEF
$20.1B
– –
-1,000
Closed -$30.3M
PANW icon
128
Palo Alto Networks
PANW
$270B
– –
-60,012
Closed -$1.72M
PRGO icon
129
CALL
Perrigo
PRGO
$1.4B
– –
-547
Closed -$8.6M
PRTA icon
130
Prothena Corp
PRTA
$425M
– –
-45,133
Closed -$2.05M
PTCT icon
131
CALL
PTC Therapeutics
PTCT
$5.68B
– –
-1,600
Closed -$4.27M
RARE icon
132
Ultragenyx Pharmaceutical
RARE
$2.45B
– –
-30,700
Closed -$2.96M
SRPT icon
133
Sarepta Therapeutics
SRPT
$1.57B
– –
-55,000
Closed -$1.77M
TXMD icon
134
TherapeuticsMD
TXMD
$23.5M
– –
-10,250
Closed -$3M
UTHR icon
135
United Therapeutics
UTHR
$25.8B
– –
-28,840
Closed -$3.79M
VTRS icon
136
Viatris
VTRS
$20.4B
– –
-200,000
Closed -$9.62M
XLV icon
137
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
– –
-10,000
Closed -$66.2M
XLY icon
138
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
– –
-178,432
Closed -$6.63M
MRTX
139
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-80,000
Closed -$2.75M
ICPT
140
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-17,500
Closed -$2.9M
EPZM
141
DELISTED
Epizyme, Inc
EPZM
– –
-150,000
Closed -$1.93M
AMAG
142
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-85,230
Closed -$3.39M
AIMT
143
DELISTED
Aimmune Therapeutics
AIMT
– –
-200
Closed -$5K
ONCE
144
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-70,000
Closed -$2.92M
ARRY
145
CALL
DELISTED
Array Biopharma Inc
ARRY
– –
-7,500
Closed -$3.42M
HZNP
146
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-3,500
Closed -$6.94M
HZNP
147
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-200,000
Closed -$3.96M
KERX
148
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-700,000
Closed -$2.46M
CEMP
149
DELISTED
Cempra, Inc.
CEMP
– –
-75,000
Closed -$2.09M
AEGR
150
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-150,000
Closed -$2.04M
3 4 5
6
7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sphera Funds Management held 153 positions worth $683M, down 13% from $784M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sphera Funds Management withdrew a net $82.5M in Q4 2015, closing 35 positions and reducing 53 holdings. Its most notable exit was Elbit Systems, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 56% a quarter earlier, followed by Utilities and Technology.

Against the trend, Sphera Funds Management opened a new position in Alphabet (Google) Class C worth $5.76M.

  • Sphera Funds Management's largest Q4 2015 buy was Alphabet (Google) Class C: 148,180 shares worth $5.76M.
  • Sphera Funds Management added most to Pfizer in Q4 2015, an estimated $20M increase.
  • Sphera Funds Management's biggest Q4 2015 reduction was Shire pic, cutting an estimated $27M.
  • Sphera Funds Management fully exited Elbit Systems in Q4 2015, selling an estimated $29.2M.
  • Sphera Funds Management's ten largest holdings make up 52% of its $683M portfolio in Q4 2015.
  • Sphera Funds Management opened 26 new positions and closed 35 in Q4 2015.
  • Sphera Funds Management's portfolio value fell 13% quarter-over-quarter to $683M.

Based on Sphera Funds Management's 13F filing for Q4 2015, filed 11 Feb 2016.